Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001213900-20-041934
Filing Date
2020-12-10
Accepted
2020-12-10 08:41:49
Documents
2

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea131373-8k_aytubioscience.htm 425 26755
2 PRESS RELEASE ISSUED BY AYTU BIOSCIENCE, INC., DATED DECEMBER 10, 2020 ea131373ex99-1_aytubio.htm EX-99.1 37885
  Complete submission text file 0001213900-20-041934.txt   66603
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Filed by) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Subject) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-38247 | Film No.: 201379573
SIC: 2834 Pharmaceutical Preparations